These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration. Kaul S; Kanthasamy A; Kitazawa M; Anantharam V; Kanthasamy AG Eur J Neurosci; 2003 Sep; 18(6):1387-401. PubMed ID: 14511319 [TBL] [Abstract][Full Text] [Related]
3. Compensatory caspase activation in MPP+-induced cell death in dopaminergic neurons. Chee JL; Guan XL; Lee JY; Dong B; Leong SM; Ong EH; Liou AK; Lim TM Cell Mol Life Sci; 2005 Jan; 62(2):227-38. PubMed ID: 15666094 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells. Wang J; Duhart HM; Xu Z; Patterson TA; Newport GD; Ali SF Neurochem Int; 2008 May; 52(6):1037-43. PubMed ID: 18069091 [TBL] [Abstract][Full Text] [Related]
5. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway. Zhai A; Zhu X; Wang X; Chen R; Wang H Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells. Anantharam V; Kaul S; Song C; Kanthasamy A; Kanthasamy AG Neurotoxicology; 2007 Sep; 28(5):988-97. PubMed ID: 17904225 [TBL] [Abstract][Full Text] [Related]
7. Characterization of MPP(+)-induced cell death in a dopaminergic neuronal cell line: role of macromolecule synthesis, cytosolic calcium, caspase, and Bcl-2-related proteins. Choi WS; Canzoniero LM; Sensi SL; O'Malley KL; Gwag BJ; Sohn S; Kim JE; Oh TH; Lee EB; Oh YJ Exp Neurol; 1999 Sep; 159(1):274-82. PubMed ID: 10486196 [TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of MPP+-treated MN9D cells: a mechanism of toxicity study. Wang J; Xu Z; Fang H; Duhart HM; Patterson TA; Ali SF Neurotoxicology; 2007 Sep; 28(5):979-87. PubMed ID: 17475336 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells. Zhang S; Wang J; Song N; Xie J; Jiang H Neurobiol Aging; 2009 Sep; 30(9):1466-76. PubMed ID: 18191877 [TBL] [Abstract][Full Text] [Related]
10. Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment. Han BS; Hong HS; Choi WS; Markelonis GJ; Oh TH; Oh YJ J Neurosci; 2003 Jun; 23(12):5069-78. PubMed ID: 12832530 [TBL] [Abstract][Full Text] [Related]
12. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway. Teng X; Sakai T; Liu L; Sakai R; Kaji R; Fukui K J Neurochem; 2006 May; 97(4):1126-35. PubMed ID: 16686692 [TBL] [Abstract][Full Text] [Related]
13. NF-kappaB mediates MPP+-induced apoptotic cell death in neuroblastoma cells SH-EP1 through JNK and c-Jun/AP-1. Yang HJ; Wang L; Xia YY; Chang PN; Feng ZW Neurochem Int; 2010 Jan; 56(1):128-34. PubMed ID: 19778565 [TBL] [Abstract][Full Text] [Related]
14. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats. Pain S; Barrier L; Deguil J; Milin S; Piriou A; Fauconneau B; Page G Toxicology; 2008 Jan; 243(1-2):124-37. PubMed ID: 18037221 [TBL] [Abstract][Full Text] [Related]
15. An in vitro model of human dopaminergic neurons derived from embryonic stem cells: MPP+ toxicity and GDNF neuroprotection. Zeng X; Chen J; Deng X; Liu Y; Rao MS; Cadet JL; Freed WJ Neuropsychopharmacology; 2006 Dec; 31(12):2708-15. PubMed ID: 17109014 [TBL] [Abstract][Full Text] [Related]
16. MPP+ inhibits proliferation of PC12 cells by a p21(WAF1/Cip1)-dependent pathway and induces cell death in cells lacking p21(WAF1/Cip1). Soldner F; Weller M; Haid S; Beinroth S; Miller SW; Wüllner U; Davis RE; Dichgans J; Klockgether T; Schulz JB Exp Cell Res; 1999 Jul; 250(1):75-85. PubMed ID: 10388522 [TBL] [Abstract][Full Text] [Related]
17. Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death. Kaul S; Anantharam V; Kanthasamy A; Kanthasamy AG Brain Res Mol Brain Res; 2005 Sep; 139(1):137-52. PubMed ID: 15978696 [TBL] [Abstract][Full Text] [Related]
18. Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. Choi WS; Yoon SY; Oh TH; Choi EJ; O'Malley KL; Oh YJ J Neurosci Res; 1999 Jul; 57(1):86-94. PubMed ID: 10397638 [TBL] [Abstract][Full Text] [Related]
19. Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens. Zhang Y; Bhavnani BR BMC Neurosci; 2006 Jun; 7():49. PubMed ID: 16776830 [TBL] [Abstract][Full Text] [Related]
20. PDNF, a human parasite-derived mimic of neurotrophic factors, prevents caspase activation, free radical formation, and death of dopaminergic cells exposed to the Parkinsonism-inducing neurotoxin MPP+. Chuenkova MV; Pereira MA Brain Res Mol Brain Res; 2003 Nov; 119(1):50-61. PubMed ID: 14597229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]